Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Microfluidics Chip

By Drug Discovery Trends Editor | April 23, 2010

Trinean, a spin-off from the University of Ghent and the IMEC research centre, launched their DropSense96 and accompanying DropPlate 16 U in December of 2009. The DropPlate 16 U enabled a measuring scope of 5 ng up to 3,200 ng/µl dsDNA. However, 80% of the principal users of Trinean products analyze genomic DNA, demanding the lowest possible volume requirements for a thorough analysis. In order to meet their needs, Trinean developed a variation of its current chip disposable, specifically for genomic researchers: the DropPlate 16 G (G stands for Genomic).

With the new DropPlate 16 G, volumes of 2 µl are sufficient to provide the researcher with a full UV/VIS scan analysis. Not only does it lower the volume requirements, but the time needed has been reduced by almost 50 %: now labs only have to wait 5 minutes before their 96 samples are analyzed, whereas it used to be 9. This difference in efficiency is even greater compared to the manual operations one had to perform before the DropSense 96 and DropPlate 16 were in use (typically 45 minutes for 96 samples).

In the 6 months since the launch of the DropSense 96, Trinean has installed over 25 units. Labs around the world, from academic research centres to pharmaceutical companies, are relying on this state-of-the-art polychromatic plate reader. Integration with existing microplate liquid handlers and robots makes this quantification automatic. 

Trinean


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE